Trial Details

Not Recruiting
Basic Information
Clinical ID c2948
Identifier JPRN-UMIN000021421
Trial Title Continuous intravenous adrenomedullin therapy for patients with inflammatory bowel disease (ulcerative colitis and Crohn's disease) - Adrenomedullin therapy for patients with inflammatory bowel disease
Trial URL Visit Original Page
Study Information
Study Results

Yes
Conditions inflammatory bowel disease (ulcerative colitis and Crohn's disease)
Interventions Period up to 2 weeks (14 days) Drug dose continuous intravenous administration of adrenomedullin 1.5 pmol/kg/min for 8 hours per day (09:00 to 17:00)
Participant Information
Sponsor First Department of Internal Medicine, Faculty of Medicine, University of Miyazaki
City -
Country/Region Japan
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type Interventional
Phase PHASE1
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date 2017-06-30